Literature DB >> 22105235

Bordetella pertussis IgG and IgA antibodies seroprevalence among 1-35 y-old population: the role of subclinical pertussis infection.

Mohammed-Jafar Saffar1, Ali-Reza Khalilian, Ali-Reza Rafee, Mohammed Reza Parsaei, Shadi Imanikhani, Jalil Shojaei, Hana Saffar.   

Abstract

OBJECTIVE: To determine age-dependent pertussis specific IgG and IgA antibodies seroprevalence in apparently healthy subjects.
METHODS: A total of 595 healthy 1-35-y-old individuals divided into 5 different age groups were selected from Sari district. Antipertussis IgG and IgA antibodies levels were measured quantitatively by ELISA method. Positive sera for IgA and also IgG titer ≥150 were considered for recent pertussis infection.
RESULTS: High seroprevelence levels (72% and 71%) were observed among preschool (<7 y) children. After decreasing the seroprevelence rates significally to lowest level (54.4%) among school aged (7-11 y), the rates increased again to the highest levels of 60% and 73% at adulthood (P = 0.03 and P = 0.003). In total, 1.55% of study subjects were IgA positive, and 5.7% showed high IgG titers.
CONCLUSIONS: The present study reveals, vaccine induced immunity has decreased among school-aged children and natural pertussis infection is common among adolescent and young adults. Also, asymptomatic/sub-clinical recent pertussis infection was prevalent among studied population. These findings necessitate developing new strategies to reduce and control pertussis infection in Iran.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22105235     DOI: 10.1007/s12098-011-0593-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  16 in total

1.  Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.

Authors:  H E de Melker; F G Versteegh; M A Conyn-Van Spaendonck; L H Elvers; G A Berbers; A van Der Zee; J F Schellekens
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Duration of immunity against pertussis after natural infection or vaccination.

Authors:  Aaron M Wendelboe; Annelies Van Rie; Stefania Salmaso; Janet A Englund
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

Review 3.  Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents.

Authors:  David P Greenberg
Journal:  Pediatr Infect Dis J       Date:  2005-08       Impact factor: 2.129

4.  The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years.

Authors:  L A Cattaneo; G W Reed; D H Haase; M J Wills; K M Edwards
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

5.  Clinical manifestations of Bordetella pertussis infection in immunized children and young adults.

Authors:  E Yaari; Y Yafe-Zimerman; S B Schwartz; P E Slater; P Shvartzman; N Andoren; D Branski; E Kerem
Journal:  Chest       Date:  1999-05       Impact factor: 9.410

6.  Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine.

Authors:  Patrick Olin; Lennart Gustafsson; Luis Barreto; Luc Hessel; T Christopher Mast; Annelies Van Rie; Hugues Bogaerts; Jann Storsaeter
Journal:  Vaccine       Date:  2003-05-16       Impact factor: 3.641

7.  Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study.

Authors:  P García-Corbeira; R Dal-Ré; L Aguilar; J García-de-Lomas
Journal:  Vaccine       Date:  2000-04-28       Impact factor: 3.641

Review 8.  Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives.

Authors:  James D Cherry; Emmanuel Grimprel; Nicole Guiso; Ulrich Heininger; Jussi Mertsola
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

9.  Pertussis seroimmunity among mother-infant pairs and infant immune response to pertussis vaccination.

Authors:  M J Saffar; A Ajami; A R Khalilian; A Qaheri; H Saffar
Journal:  Indian Pediatr       Date:  2007-12       Impact factor: 1.411

10.  Pertussis symptoms in adolescents and children versus infants: the influence of vaccination and age.

Authors:  Tal Eidlitz-Markus; Marc Mimouni; Avraham Zeharia
Journal:  Clin Pediatr (Phila)       Date:  2007-05-23       Impact factor: 1.168

View more
  6 in total

Review 1.  Immune persistence after pertussis vaccination.

Authors:  Zhiyun Chen; Qiushui He
Journal:  Hum Vaccin Immunother       Date:  2017-01-03       Impact factor: 3.452

2.  Pertussis resurgence in a highly vaccinated population, Mazandaran, North of Iran 2008-2011: an epidemiological analysis.

Authors:  Mohammad Jafar Saffar; Gholamreza Ghorbani; Ahmad Hashemi; Mohammad Sadegh Rezai
Journal:  Indian J Pediatr       Date:  2014-05-02       Impact factor: 1.967

3.  Understanding Trends in Pertussis Incidence: An Agent-Based Model Approach.

Authors:  Erinn Sanstead; Cynthia Kenyon; Seth Rowley; Eva Enns; Claudia Miller; Kristen Ehresmann; Shalini Kulasingam
Journal:  Am J Public Health       Date:  2015-07-16       Impact factor: 9.308

4.  Clinical and laboratory features of pertussis in hospitalized infants with confirmed versus probable pertussis cases.

Authors:  J Shojaei; Mj Saffar; A Hashemi; Gr Ghorbani; Ms Rezai; S Shahmohammadi
Journal:  Ann Med Health Sci Res       Date:  2014-11

Review 5.  Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in the Middle East.

Authors:  Denis Macina; Keith E Evans
Journal:  Infect Dis Ther       Date:  2021-04-27

6.  Seroprevalence of Bordetella pertussis among a nationally representative sample of Iranian pediatric population: The childhood and adolescence surveillance and prevention of adult noncommunicable disease-V study.

Authors:  Zary Nokhodian; Behrooz Ataei; Seyed Mohsen Zahraei; Mohammad Mehdi Gouya; Shervin Ghaffari Hoseini; Majid Yaran; Marjan Mansourian; Mohammad Esmaeil Motlagh; Ramin Heshmat; Roya Kelishadi
Journal:  J Res Med Sci       Date:  2021-03-31       Impact factor: 1.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.